Wolverine Trading, LLC Summit Therapeutics Inc. Call Options Transaction History

Wolverine Trading, LLC

  • $83.2 Billion
  • Q1 2025

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2025

May 15, 2025
SELL
$16.65 - $23.76 $224,774 - $320,760
-13,500 Reduced 15.03%
76,300 $1.47 Million
Q4 2024

Feb 14, 2025
SELL
$17.52 - $23.46 $837,456 - $1.12 Million
-47,800 Reduced 34.74%
89,800 $1.6 Million
Q3 2024

Nov 14, 2024
BUY
$6.89 - $31.93 $722,072 - $3.35 Million
104,800 Added 319.51%
137,600 $3.01 Million
Q2 2024

Aug 14, 2024
BUY
$2.39 - $10.92 $78,392 - $358,176
32,800 New
32,800 $255,000

Others Institutions Holding SMMT

# of Institutions
236
Shares Held
86.8M
Call Options Held
1.84M
Put Options Held
3.13M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.67B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email